What broader implications does the FDA’s reversal on leucovorin labeling have for the regulatory pathway of off‑label drug uses, and how might this shift influence biotech investment strategies in neurodevelopmental therapies?

In what ways does granting asylum to Iranian soccer players under political pressure illustrate the nexus of sports diplomacy, human‑rights advocacy, and U.S. immigration policy, and what precedents might it set for future geopolitical asylum cases?

What systemic effects could the United States’ self‑determined timeline for ending hostilities with Iran have on international conflict‑de‑escalation norms and the credibility of American strategic signaling?